The Relative Strength (RS) Rating for Envista Holdings moved up into a higher percentile Tuesday, as it got a lift from 62 to 72.
IBD's proprietary RS Rating identifies technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Over 100 years of market history shows that the best-performing stocks tend to have an RS Rating of over 80 as they begin their biggest runs. See if Envista Holdings can continue to rebound and hit that benchmark.
Can You Really Time The Stock Market?
While the stock is not near an ideal buying range right now, see if it goes on to form and break out of a proper base.
Earnings growth rose in the company's latest report from -74% to -72%, but revenue fell from -4% to -5%.
The company earns the No. 30 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical, Brainsway ADR and Electromed are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
